The use of TCZ showed a trend of benefit that did not reach statistical significance as an independent protective factor.
← all excerpts
The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers.
1
—
—
The use of TCZ showed a trend of benefit that did not reach statistical significance as an independent protective factor.